Related Experiment Video
Updated: Feb 22, 2026

09:33
Diffusion Tensor Magnetic Resonance Imaging in the Analysis of Neurodegenerative Diseases
Published on: July 28, 2013
29.4K
Advancing functional dysconnectivity and atrophy in progressive supranuclear palsy.
Jesse A Brown1, Alice Y Hua1, Andrew Trujllo1
1Memory and Aging Center, Department of Neurology, University of California San Francisco, San Francisco, CA, USA.
Neuroimage. Clinical
|September 28, 2017
Summary
Neuroimaging reveals progressive supranuclear palsy syndrome (PSP-S) involves brain network decline, with early atrophy in subcortical and frontal regions, followed by parietal changes and altered connectivity over time.
Area of Science:
- Neuroscience
- Neurology
- Medical Imaging
Background:
- Progressive supranuclear palsy syndrome (PSP-S) involves neurodegeneration across multiple brain regions.
- The progression of network dysfunction and its relation to atrophy and clinical decline in PSP-S remain unclear.
Purpose of the Study:
- To investigate the longitudinal progression of network dysfunction, atrophy, and clinical decline in PSP-S.
- To correlate neuroimaging findings with clinical severity and progression in PSP-S patients.
Main Methods:
- Structural MRI and task-free functional MRI (tf-fMRI) were used to assess 12 PSP-S patients and 20 controls at baseline and 6 months.
- Voxel-based morphometry (VBM) analyzed structural atrophy, while functional connectivity (FC) was examined in a rostral midbrain tegmentum (rMT)-anchored network.
Main Results:
- Baseline VBM showed atrophy in subcortex, brainstem, prefrontal cortex (PFC), and parietal cortex in PSP-S patients.
- Baseline tf-fMRI revealed FC deficits in PSP-S within rMT network hubs, particularly in prefrontal-paralimbic and subcortical-brainstem modules.
- Longitudinally, PSP-S patients exhibited declining intermodular FC between subcortical-brainstem and parietal modules, alongside progressive atrophy in midbrain, pallidum, and posterior frontal cortex.
Conclusions:
- PSP-S progression may involve an earlier subcortical-anterior cortical disease process followed by later subcortical-posterior cortical changes.
- Neuroimaging markers (VBM and FC) can track disease stages and heterogeneous clinical progression in PSP-S, aiding disease monitoring.
More Related Videos
Related Concept Videos
Parkinson's Disease: Overview
2.2K
Neurodegenerative disorders are progressive diseases that cause irreversible damage and loss to neurons in specific brain areas. Examples of these disorders include Parkinson's disease, Alzheimer's disease, Multiple Sclerosis (MS), and Amyotrophic Lateral Sclerosis (ALS). These disorders share characteristics such as proteinopathies, selective neuronal vulnerability, and a complex interplay between genetic and environmental factors. The primary therapeutic goal for these conditions is...
2.2K
Neural Regulation
43.6K
Digestion begins with a cephalic phase that prepares the digestive system to receive food. When our brain processes visual or olfactory information about food, it triggers impulses in the cranial nerves innervating the salivary glands and stomach to prepare for food.
43.6K
Alzheimer's Disease: Overview
1.8K
Alzheimer's Disease (AD) is a continually advancing neurodegenerative disorder, distinguished by escalating memory loss, cognitive dysfunction, and dementia. The disease unfolds in three stages: preclinical, mild cognitive impairment (MCI), and dementia. Its onset is insidious, and the progression gradual, with the cause not well explained by other disorders.
The clinical diagnosis of AD hinges on the presence of memory and other cognitive impairments. Biomarkers, such as changes in Aβ...
The clinical diagnosis of AD hinges on the presence of memory and other cognitive impairments. Biomarkers, such as changes in Aβ...
1.8K

